newsfilter
← Latest News
Business Wire·

Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2022

Appili Therapeutics Inc. (TSX:APLI, OTCQX:APLIF) (the "Company" or "Appili"), a biopharmaceutical company developing anti-infective drug candidates, today announced its financial and operational results for the first quarter of its fiscal year 2022, whi